MarketReserchReports.biz
has recently announced the addition of a market study “
Inhalation and Nasal Spray Generic Drugs Market:(By Drug Class:
Corticosteroids, Bronchodilators, Antihistamines, Combinations, and
Decongestant Sprays; By Application: Asthma, COPD, Allergic Rhinitis,
and Others) Global Industry Analysis, Size, Share, Growth, Trends and
Forecast 2015 - 2023 ”
This
report on the inhalation and nasal spray generic drugs market studies
the current and future prospects of the global market. Growing
incidences of respiratory diseases such as asthma and COPD,
increasing geriatric population, and increasing number of generic
manufacturers is expected to accentuate the growth of inhalation and
nasal spray generic drugs market globally. The Inhalation
And Nasal Spray Generic Drugs Market report
comprises an elaborate executive summary, which includes a market
snapshot that provides information about various segments and
sub-segments of the market. It also provides information and data
analysis of the global inhalation and nasal spray generic drugs
market with respect to market segments based on drug class, medical
indication and their geographic analysis.
Based
on drug class, the inhalation and nasal spray generic drugs market
has been segmented into five major categories: corticosteroids,
bronchodilators, antihistamines, combinations, and decongestant
sprays. The market segments have been extensively analyzed based on
usefulness, efficacy, revenue, and geographical coverage. The market
size and forecast in terms of US$ Mn for each segment has been
provided for the period from 2013 to 2023. The report also provides
the compound annual growth rate (CAGR %) for each market segment for
the forecast period from 2015 to 2023, considering 2014 as the base
year.
Download
Sample copy of this Report at
http://www.marketresearchreports.biz/sample/sample/194592
Geographically,
the global inhalation and nasal spray generic drugs market has been
categorized into six major regions: North America, Europe, Asia
Pacific, Latin America, Middle East and North Africa, and Rest of the
World. The market size and forecast for each of these regions has
been provided for the period from 2013 to 2023, along with their
respective CAGRs for the forecast period from 2015 to 2023,
considering 2014 as the base year. The research study also covers the
competitive scenario in these regions. A detailed qualitative
analysis of factors responsible for driving and restraining the
growth of the market and future opportunities has been provided in
the market overview section. This section of the report also provides
market attractiveness analysis by drug class and geography, as well
as market share analysis by key players, thus presenting a thorough
analysis of the overall competitive scenario in the global inhalation
and nasal spray generic drugs market.
Current
and future trends has also been provided for new entrants as well as
existing market players to assist them in taking strategic
initiatives to establish a strong presence in the market. The report
also profiles major players in the inhalation and nasal spray generic
drugs market based on various attributes such as company overview,
financial overview, product portfolio, business strategies, and
recent developments. Major players profiled in this report include
Teva Pharmaceutical Industries Ltd., Sandoz International GmbH
(Novartis AG), Allergan plc, Mylan N.V., Ranbaxy Laboraotries Ltd.,
Roxane Laboratories, Inc., Beximco Pharmaceuticals Ltd., Cipla Ltd.,
and Nephron Pharmaceuticals Corporation.
Browse
All reports Of this Category:
http://www.marketresearchreports.biz/category/38
The
global inhalation and nasal spray generic drugs market is segmented
as given below:
Global
Inhalation and Nasal Spray Generic Drugs Market, by Drug Class,
2013-2023 (US$ Mn)
- Corticosteroids
- Fluticasone
- Budesonide
- Beclomethasone
- Flunisolide
- Others (mometasone, ciclesonide etc.)
- Bronchodilators
- Albuterol
- Epinephrine
- Others
- Antihistamines
- Combinations
- Salmeterol/Fluticasone
- Formoterol/Budesonide
- Azelastine/Benzalkonium Chloride
- Others
- Decongestant Sprays
- Phenylephrine hydrochloride
- Oxymetazoline hydrochloride
Global
Inhalation and Nasal Spray Generic Drugs Market, by Drug Class,
2013-2023 (US$ Mn)
- Asthma
- COPD
- Allergic Rhinitis
- Other Respiratory Disorders
Global
Inhalation and Nasal Spray Generic Drugs Market, by Geography, 2013 –
2023 (US$ Mn)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Rest of Europe
- Asia-Pacific
- China
- Japan
- Australia
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and North Africa
- Saudi Arabia
- Egypt
- United Arab Emirates
Browse
Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz
Table
Of Content
1.
Preface
1.1.
Report Description
1.2.
Market Segmentation
1.3.
Research Methodology
2.
Executive Summary
2.1.
Global Inhalation and Nasal Spray Generic Drugs Market Revenue,
2013–2023 (US$ Mn)
2.2.
Global Inhalation and Nasal Spray Generic Drugs Market Revenue, by
Drug Class, 2014 (US$ Mn)
2.3.
Global Inhalation and Nasal Spray Generic Drugs Market Revenue, by
Medical Indication, 2014 (US$ Mn)
2.4.
Global Market Share by Geography, 2014 and 2023 (Value %)
2.5.
Inhalation and Nasal Spray Generic Drugs Market Snapshot
3.
Global Inhalation and Nasal Spray Generic Drugs Market – Industry
Analysis
3.1.
Introduction
3.2.
Drivers
3.2.1.
Rise in incidence of asthma, COPD, and other respiratory diseases to
provide an impetus for growth
3.2.2.
Low cost involved with generic prescription drugs
3.3.
Restraints
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment